Skip to content

Comparison of Effects of Eggshell Derived Nano Hydroxyapatite and Hydroxyapatite in Management of Periodontal Intrabony Defects

Comparative Efficacy Of Eggshell Derived Nano Hydroxyapatite Over Hydroxyapatite In The Treatment Of Periodontal Intrabony Defects: A Clinico-Radiographic Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07160101
Enrollment
28
Registered
2025-09-08
Start date
2023-03-22
Completion date
2025-03-27
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Regeneration, Periodontal Intrabony Defects

Brief summary

The aim of the study is to evaluate osseous regenerative efficacy of eggshell derived nanohydroxyapatite in comparison with hydroxyapatite The test group includes patients with intrabony defects where flap surgery will be performed & Eggshell derived nano hydroxyapatite (ESnHA) is placed.

Detailed description

Experimental : Main treatment group Eggshell derived nano hydroxyapatite is placed into defect site Comparator : In patients allocated to control group, only Hydroxyapatite is placed.

Interventions

OTHEREggshell derived nano hydroxyapatite

Eggshell derived nano hydroxyapatite has high solubility and allows faster integration & replaces with osseous tissue

Hydroxyapatite has similar chemical composition with crystalline structure of native bone

Sponsors

Dr R Viswa Chandra
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

Presence of Two-walled or three-walled intrabony defects & Probing pocket depths (PPD) of \>5mm after initial therapy Systemically healthy male and female patients of age \>18 years

Exclusion criteria

Medically compromised patients Pregnant women, Heavy smokers, and Patients who underwent radiotherapy or chemotherapy

Design outcomes

Primary

MeasureTime frameDescription
RVG3months & 6monthsRadiovisiography will be used to assess bone regeneration achieved post operatively
Probing Depth3 months & 6months
Clinical Attachment Level3 months & 6 months

Secondary

MeasureTime frameDescription
Full mouth Plaque index3 months & 6 monthsFull mouth plaque index was measured using Turesky modification of the Quigley-Hein Index at baseline, 3 months and 6 months
Full mouth Gingival index3 months & 6 monthsFull mouth gingival index was measured using Loe & Silness Index at baseline, 3 months and 6 months

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026